ACCESS

Among the priority actions articulated by ACCESS stakeholders was the need for improvements in drug procurement through accurate forecasting and innovative financing. The establishment of a Global Childhood Cancer Drug Bank, modeled on existing initiatives for vaccines and antimicrobials (GAVI, The Vaccine Alliance), was endorsed as a key component of efforts to ensure an efficient, cost-effective, consistent, and quality supply of essential cancer medicines for children... Access to essential medicines is one of the key determinants of childhood cancer survival globally. The World Health Organization's (WHO) Essential Medicines List (EML) sets the basic bar that all national governments should meet in the provision of medicines. The recently revised EML includes an expanded list of core medicines required for multiple cancer treatments, including the most prevalent childhood cancers (EMLc). Ensuring access to such medicines is an explicit component of the broader right to health..